Market Whales and Their Recent Bets on LLY Options
Market Whales and Their Recent Bets on LLY Options
Financial giants have made a conspicuous bearish move on Eli Lilly and Co. Our analysis of options history for Eli Lilly and Co (NYSE:LLY) revealed 15 unusual trades.
金融巨头对礼来公司采取了明显的看跌举动。我们对礼来公司（纽约证券交易所代码：LLY）期权历史的分析显示了15笔不寻常的交易。
Delving into the details, we found 26% of traders were bullish, while 33% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $881,458, and 10 were calls, valued at $903,584.
深入研究细节，我们发现26％的交易者看涨，而33％的交易者表现出看跌趋势。在我们发现的所有交易中，有5笔是看跌期权，价值为881,458美元，10笔是看涨期权，价值903,584美元。
Predicted Price Range
预测的价格区间
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $430.0 and $980.0 for Eli Lilly and Co, spanning the last three months.
在评估了交易量和未平仓合约之后，很明显，主要市场走势者正在关注过去三个月中礼来公司在430.0美元至980.0美元之间的价格区间。
Volume & Open Interest Development
交易量和未平仓合约的发展
In today's trading context, the average open interest for options of Eli Lilly and Co stands at 563.62, with a total volume reaching 297.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Eli Lilly and Co, situated within the strike price corridor from $430.0 to $980.0, throughout the last 30 days.
在今天的交易背景下，礼来公司期权的平均未平仓合约为563.62，总成交量达到297.00。随附的图表描绘了过去30天内位于行使价走廊内从430.0美元到980.0美元的高价值交易的看涨和看跌期权交易量以及未平仓合约的变化。
Eli Lilly and Co Option Volume And Open Interest Over Last 30 Days
过去30天礼来公司的期权交易量和未平仓合约
Largest Options Trades Observed:
观察到的最大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | PUT | SWEEP | BEARISH | 07/26/24 | $64.0 | $61.35 | $64.0 | $935.00 | $640.0K | 150 | 100 |
| LLY | CALL | SWEEP | BULLISH | 01/17/25 | $142.9 | $137.8 | $140.78 | $780.00 | $281.9K | 3.5K | 0 |
| LLY | CALL | SWEEP | NEUTRAL | 01/17/25 | $142.7 | $138.6 | $140.68 | $780.00 | $253.4K | 3.5K | 41 |
| LLY | PUT | TRADE | BULLISH | 07/26/24 | $77.3 | $72.3 | $72.3 | $940.00 | $108.4K | 103 | 15 |
| LLY | PUT | TRADE | BEARISH | 07/26/24 | $14.6 | $10.85 | $14.6 | $870.00 | $73.0K | 431 | 0 |
| 符号 | 看跌/看涨 | 交易类型 | 情绪 | Exp。日期 | 问 | 出价 | 价格 | 行使价 | 总交易价格 | 未平仓合约 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 莉莉 | 放 | 扫 | 粗鲁的 | 07/26/24 | 64.0 美元 | 61.35 美元 | 64.0 美元 | 935.00 美元 | 640.0 万美元 | 150 | 100 |
| 莉莉 | 打电话 | 扫 | 看涨 | 01/17/25 | 142.9 美元 | 137.8 美元 | 140.78 美元 | 780.00 美元 | 281.9 万美元 | 3.5K | 0 |
| 莉莉 | 打电话 | 扫 | 中立 | 01/17/25 | 142.7 美元 | 138.6 美元 | 140.68 美元 | 780.00 美元 | 253.4 万美元 | 3.5K | 41 |
| 莉莉 | 放 | 贸易 | 看涨 | 07/26/24 | 77.3 美元 | 72.3 美元 | 72.3 美元 | 940.00 美元 | 108.4 万美元 | 103 | 15 |
| 莉莉 | 放 | 贸易 | 粗鲁的 | 07/26/24 | 14.6 美元 | 10.85 美元 | 14.6 美元 | 870.00 美元 | 73.0 万美元 | 431 | 0 |
About Eli Lilly and Co
关于 Eli Lilly and Co
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
礼来是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。礼来公司的主要产品包括治疗癌症的Verzenio；用于治疗糖尿病的Mounjaro、Zepbound、Jardiance、Trulicity、Humalog和Humulin；以及用于免疫学的Taltz和Olumiant。
After a thorough review of the options trading surrounding Eli Lilly and Co, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
在对礼来公司的期权交易进行了全面审查之后，我们将对该公司进行更详细的审查。这包括评估其当前的市场状况和表现。
Current Position of Eli Lilly and Co
礼来公司目前的职位
- With a volume of 73,482, the price of LLY is up 0.45% at $869.85.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 16 days.
- LLY的交易量为73,482美元，价格上涨0.45％，至869.85美元。
- RSI 指标暗示，标的股票目前在超买和超卖之间保持中立。
- 下一份财报预计将在16天内公布。
Professional Analyst Ratings for Eli Lilly and Co
礼来公司的专业分析师评级
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $959.0.
在过去的一个月中，5位行业分析师分享了他们对该股的见解，提出平均目标价为959.0美元。
- Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $885.
- Consistent in their evaluation, an analyst from Berenberg keeps a Buy rating on Eli Lilly and Co with a target price of $1000.
- An analyst from Barclays persists with their Overweight rating on Eli Lilly and Co, maintaining a target price of $1025.
- Reflecting concerns, an analyst from Truist Securities lowers its rating to Buy with a new price target of $1000.
- In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $885.
- 坎托·菲茨杰拉德的一位分析师将其评级下调至增持，新的目标股价为885美元，这反映了人们的担忧。
- 贝伦贝格的一位分析师在评估中保持了对礼来公司的买入评级，目标价为1000美元。
- 巴克莱银行的一位分析师坚持对礼来公司的增持评级，将目标价维持在1025美元。
- 出于担忧，Truist Securities的一位分析师将其评级下调至买入，新的目标股价为1000美元。
- 坎托·菲茨杰拉德的一位分析师谨慎地将其评级下调至增持，将目标股价定为885美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
与仅交易股票相比，期权是一种风险更高的资产，但它们具有更高的获利潜力。严肃的期权交易者通过每天自我教育、扩大交易规模、关注多个指标以及密切关注市场来管理这种风险。